Epirubicin, cisplatin, and 5-fluorouracil in the treatment of advanced gastro-oesophageal cancer when prolonged infusional therapy is not feasible

GI Cancer

Volumn 3, Issue 3, 2000, Pages 199-206

  Karapetis, C S ^a   Yip, D ^a   Strickland, A ^a   Lo, S K ^a   Benepal, T ^a   Cowling, M ^a   Harper, P G ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

5 Fluorouracil; Chemotherapy; Cisplatin; Epirubicin; Oesophageal cancer; Stomach cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; EPIRUBICIN; FLUOROURACIL;

ADENOCARCINOMA; ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER SURVIVAL; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; DIARRHEA; ESOPHAGUS CANCER; FEMALE; HUMAN; KIDNEY DISEASE; LEUKOPENIA; MALE; NAUSEA; NEUROTOXICITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; STOMATITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; UNDIFFERENTIATED CARCINOMA;

EID: 0034023099     PISSN: 10649700     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)